Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.

Human peripheral blood polymorphonuclear leukocytes, when exposed to appropriate stimuli, generate significant amounts of superoxide anion (O-.2), a highly reactive molecule which is possibly involved in bacterial killing. Since the subcellular localization and mechanism of activation of O-.2 generating systems are unknown, we have investigated superoxide dismutase-inhibitable cytochrome c reduction (attributable to O-.2) by, and lysosomal enzyme release from, normal polymorphonuclear leukocytes and cells rendered incapable of ingesting particles by treatment with cytochalasin B. Neither phagocytosis nor lysosomal degranulation were prerequisites for enhanced O-.2 generation. Cytochalasin B-treated cells exposed to (a) serum-treated zymosan, a C3b receptor stimulus; (b) heat aggregated human IgG, an Fc receptor stimulus; and (c) the complement component, C5a, generated enhanced amounts of O-.2 in a time and concentration-dependent fashion. These cells also responded by releasing lysosomal enzymes, but there was no correlation between the ability of any immune reactant to provoke enzyme release and its ability to stimulate O-.2 generation. The three stimuli also enhanced O-.2 generation by normal (untreated) polymorphonuclear leukocytes, but only serum-treated zymosan and aggregated IgG were capable of provoking lysosomal enzyme release from normal cells. Untreated zymosan and native IgG neither stimulated O-.2 production nor provoked lysomal enzyme release. Since enhanced O-.2 production was stimulated by immune reactants in the absence of phagocytosis, the O-.2 generating system is very likely associated with the external plasma membrane of the polymorphonuclear leukocyte. Leukocyte membrane receptors for complement and immunoglobulins may therefore not only serve in particle recognition but also may initiate biochemical events which accompany phagocytosis and killing.

[1]  K. Rajagopalan,et al.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. , 1975, The Journal of clinical investigation.

[2]  D. Roos,et al.  Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. , 1975, The Journal of laboratory and clinical medicine.

[3]  B. Babior,et al.  Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase. , 1975, The Journal of laboratory and clinical medicine.

[4]  G. Weissmann,et al.  Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis. , 1975, Journal of immunology.

[5]  M. L. Karnovsky,et al.  Superoxide production by phagocytic leukocytes , 1975, The Journal of experimental medicine.

[6]  N. Krinsky Singlet Excited Oxygen as a Mediator of the Antibacterial Action of Leukocytes , 1974, Science.

[7]  J. McCord,et al.  Superoxide dismutases in polymorphonuclear leukocytes. , 1974, The Journal of clinical investigation.

[8]  G. Weissmann,et al.  POTASSIUM AND AMINO ACID TRANSPORT IN HUMAN LEUKOCYTES EXPOSED TO PHAGOCYTIC STIMULI , 1974, The Journal of cell biology.

[9]  J. White,et al.  Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. , 1974, Journal of Clinical Investigation.

[10]  S. Klebanoff,et al.  Role of the superoxide anion in the myeloperoxidase-mediated antimicrobial system. , 1974, The Journal of biological chemistry.

[11]  H. Movat,et al.  The visualization of receptors for the Fc portion of the IgG molecule on human neutrophil leukocytes. , 1974, Life sciences.

[12]  B. Babior,et al.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. , 1974, The Journal of clinical investigation.

[13]  J. White,et al.  The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. , 1974, The Journal of laboratory and clinical medicine.

[14]  L. Mcphail,et al.  Superoxide dismutase activity in leukocytes. , 1974, The Journal of clinical investigation.

[15]  J. White,et al.  Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate. , 1974, The American journal of pathology.

[16]  B. Babior,et al.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease. , 1974, The New England journal of medicine.

[17]  R. Estensen,et al.  Specific degranulation of human polymorphonuclear leukocytes , 1974, Nature.

[18]  G. Weissmann,et al.  Interaction of immunoglobulins with liposomes. , 1974, The Journal of clinical investigation.

[19]  P. McCay,et al.  Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. , 1973, The Journal of biological chemistry.

[20]  G. Weissmann,et al.  Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. G. Osler,et al.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation. , 1973, Journal of immunology.

[22]  H. Müller-Eberhard,et al.  FORMATION OF C3a AND C5a ANAPHYLATOXINS IN WHOLE HUMAN SERUM AFTER INHIBITION OF THE ANAPHYLATOXIN INACTIVATOR , 1973, Journal of Experimental Medicine.

[23]  R. Johnston,et al.  An abnormality of the alternate pathway of complement activation in sickle-cell disease. , 1973, The New England journal of medicine.

[24]  G. Weissmann,et al.  Cytochalasin B: effect on lysosomal enzyme release from human leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Babior,et al.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.

[26]  P. Henson,et al.  The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. , 1972, Journal of immunology.

[27]  S. Klebanoff,et al.  Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. , 1972, Journal of the Reticuloendothelial Society.

[28]  S. Zigmond,et al.  Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. , 1972, Experimental cell research.

[29]  S. Zigmond,et al.  Cytochalasin B: Inhibition of D-2-Deoxyglucose Transport into Leukocytes and Fibroblasts , 1972, Science.

[30]  R. Basford,et al.  Polymorphonuclear Leukocyte Activation: Effects of Phospholipase C , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[31]  J. Mcguire,et al.  Cytochalasin B: Effects on Microfilaments and Movement of Melanin Granules within Melanocytes , 1972, Science.

[32]  P. Henson,et al.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. , 1971, Journal of immunology.

[33]  Gerald Weissmann,et al.  MECHANISMS OF LYSOSOMAL ENZYME RELEASE FROM LEUKOCYTES EXPOSED TO IMMUNE COMPLEXES AND OTHER PARTICLES , 1971, The Journal of experimental medicine.

[34]  G. Mandell Influence of Type of Ingested Particle on Human Leukocyte Metabolism , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  N. K. Wessells,et al.  Microfilaments in Cellular and Developmental Processes , 1971, Science.

[36]  R. Messner,et al.  Receptors for human γG Globulin on human neutrophils , 1970 .

[37]  D. J. Morton,et al.  Carbohydte metabolism in leukocytes. XI. Stimulation of eosinophils and neutrophils. , 1969, Journal of the Reticuloendothelial Society.

[38]  V. Nussenzweig,et al.  RECEPTORS FOR COMPLEMENT ON LEUKOCYTES , 1968, The Journal of experimental medicine.

[39]  R. Laffin,et al.  A PREPARATIVE METHOD FOR THE SEPARATION OF 7S GAMMA GLOBULIN FROM HUMAN SERUM. , 1964, Archives of biochemistry and biophysics.

[40]  E. C. Slater,et al.  The extinction coefficient of cytochrome c. , 1962, Biochimica et biophysica acta.

[41]  B. Vallee,et al.  Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. , 1956, The New England journal of medicine.

[42]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[43]  G. Weissmann,et al.  Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. , 1974, The Journal of clinical investigation.

[44]  F. Rossi,et al.  Effect of specific antibodies on the metabolism of guinea pig polymorphonuclear leukocytes. , 1971, Journal of the Reticuloendothelial Society.

[45]  A. T. Davis,et al.  Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis. , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[46]  P. Henson The adherence of leucocytes and platelets induced by fixed IgG antibody or complement. , 1969, Immunology.

[47]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.